Get started
MEDTRONIC PLC USD0.0001MEDTRONIC PLC USD0.0001MEDTRONIC PLC USD0.0001

MEDTRONIC PLC USD0.0001

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

0Y6X trade ideas

MDT - Time for a recovery moveNYSE:MDT has not been making any lower low (closing price) in the weekly chart since W4 November 2022. Last 4h candle is breaking out the downtrend line (peak line on 21- Apr-2022) If the price can breakout $ 81.24 - 81.64 barrier, first target will be the flat target at $87.44 In the bigger picture, price around $95 will be the target for the upside (Fibo Retracement 0.5). Oscillators-wise, Stochastic remain above 50 line, MACD remain above 0 line, and DPO is returning to the positive side. Risk limit at $75.83 (6.3% risk). for short-stop, you may use EMA50 line as your SL position. the risk is around 2% at that point. Note: Disclaimer is always on. Currently I do not have any possession of NYSE:MDT stock in my portfolio.
NYSE:MDTLong
by dhimaswppr
8 Reasons Why Medtronic is a Great Investment OptionMedtronic is a medical device company that focuses on research, development, manufacturing, and distribution of various medical devices. The company has grown rapidly in the last few years thanks to its strong performance and focus on innovation. In this article, we will discuss why Medtronic remains a strong investment option with a promising future ahead. Reasons to invest in Medtronic The strong financial position of Medtronic is one of the main reasons to invest in it. The company’s debt-to-equity ratio is below 1.0, which means that its debt is well below its equity base. This is an important ratio to watch as an investor, especially if the company is heavy on debt – as that indicates that the company may run into trouble in the future especially in times like these where interest rates are going up. The company’s return on equity (ROE) is consistently above its cost of equity, which means that it is earning much more than its shareholders could expect in a risk-free investment. Similarly, Medtronic’s debt-to-asset ratio is below 40%, which shows that its debt is lower than its assets. This is important to look at when evaluating a company’s financial position, as it indicates the company is mostly likely to be able to pay back its debt even in a worst-case scenario. Strong Financial Position Another factor to consider when evaluating a company’s financial position is its liquidity. Liquidity is the ability of a company to quickly turn its assets into cash if needed. When it comes to Medtronic, the company has enough liquidity thanks to its cash on hand, cash from operations, and other short-term investments that can easily be turned into cash. Similarly, Medtronic’s current ratio (the number of current assets compared to current liabilities) is above 1.0, which indicates that the company has enough current assets to meet its current liabilities. This ratio is important to look at because it indicates whether or not a company can meet its short-term obligations while also pursuing long-term goals. Strong Track Record of Growth Through Acquisitions Medtronic has a strong track record of growth through acquisitions, having acquired dozens of companies in its history. This is important to watch out for when investing in a company – especially if it has a history of poor acquisitions. This can lead to lost capital for investors as well as a company that is unfocused. However, the acquisitions Medtronic has made have all been successful and focused around the company’s core business. This has allowed Medtronic to offer a wide range of products around the world while also keeping its R&D focused on the most important innovations. Integration of CareLink with Guardian 2 platform Another example of a successful acquisition is when Medtronic purchased CareLink in 2015 for $250 million. CareLink is a company focused on creating remote patient monitoring solutions that are designed to help patients manage chronic diseases at home. Following the acquisition, CareLink was integrated into Medtronic’s Guardian 2 remote care platform, which connects patients and doctors while also allowing patients to monitor their own health. This represents a huge opportunity for Medtronic as it expands its remote monitoring capabilities. This is especially relevant as more and more people are living with chronic conditions that require consistent monitoring. This is expected to lead to a huge opportunity for remote monitoring solutions in the future. Solid Return on Investment for Medtronic Investors When looking at the company’s return on investment (ROI), it is important to note that this is a long-term number. This means that you want to see a high ROI, but this number is not as important as a company’s short-term numbers. However, when it comes to investment, the long-term numbers are actually more important than the short-term numbers. The short-term numbers are important because they indicate how strong of a short-term investment a company is. The long-term numbers are important because they show the potential for long-term growth. Solid Base of Popular Brands/Products for Medtronic Another important factor to look at when evaluating Medtronic is its core products and brands. These are the products and brands that define Medtronic as a company, and they are what has helped the company grow over the last few decades. These products/brands can give us insight into Medtronic’s future plans, because the company has to consistently update and improve these products to meet consumer demand. Medtronic is venturing into the artificial intelligence space One of the biggest trends in the medical device industry is the adoption of artificial intelligence (AI). AI can be used to help medical devices better understand their environment and collect data/information on patients while also allowing them to communicate with other devices. This can be extremely helpful in the medical device industry, especially when it comes to remote monitoring solutions – which is an area in which Medtronic is already growing. One of Medtronic’s key acquisitions in recent years was HealthMine, which is a company focused on the AI space within medical devices. This acquisition could allow Medtronic to significantly expand its AI capabilities and help the company keep up with the latest trends in its industry. Financials EPS Dividend Yield % Valuation Metrics Summing up There are many reasons why Medtronic is a great investment option. The company has a strong financial position, a strong track record of growth through acquisitions, an integration of its CareLink acquisition with its Guardian 2 platform, a solid base of popular brands/products for Medtronic, and Medtronic is venturing into the artificial intelligence space. These are all reasons to invest in Medtronic because they show a strong future ahead.
NYSE:MDTLong
by EQTSHARES
31
Medtronic - C Wave in upgoing Zigzag. MDTGoals 199, 190, 185. Invalidation at 230. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe
NYSE:MDTLong
by Rykin_Capital
MDT Long Hard to ignore this channel in Medtronic. 43 year dividend growth streak with 23% debt to cap and a payout ratio of 44%. Yield theory, this is the highest the yield for Medtronic has been for a while, so I think that indicates a great time to long in an investment portfolio. Forward P/E is below the 5 year average as well, but I'm honestly more interested in the dividend yield being so high relative to its 5 year average. The 22% op. margin gives insight into Medtronic as having a potentially pretty wide moat in the med device space. I like it quite a bit
NYSE:MDTLong
by CG_Financial